-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
-
Summary
-
Contineum Therapeutics, Inc. quarterly Liabilities history and growth rate from Q4 2023 to Q2 2024.
- Contineum Therapeutics, Inc. Liabilities for the quarter ending June 30, 2024 was $3.85M.